Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies
✍ Scribed by Jens Benn Sorensen; Torben Skovsgaard; Ellen Bork; Lars Damstrup; Sten Ingeberg
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 92 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
The purpose was to evaluate prevention of oral mucositis (OM) using chlorhexidine compared with placebo and with oral cooling (cryotherapy) during fluorouracil (5‐FU)‐based chemotherapy in gastrointestinal (GI) cancer.
METHODS
Patients with previously untreated GI cancer receiving bolus 5‐FU/leucovorin chemotherapy were randomized to chlorhexidine mouthrinse 3 times a day for 3 weeks (Arm A), double‐blind placebo (normal saline) with the same dose and frequency (Arm B), or cryotherapy with crushed ice 45 minutes during chemotherapy (Arm C). Patients self‐reported on severity (CTC‐grading) and duration of OM.
RESULTS
Among 225 patients randomized, 206 answered the questionnaire (70, 64, and 63 patients in Arms A, B, and C, respectively) and were well balanced with respect to diagnoses, stage, age, sex, smoking habits, and performance status. Mucositis grade 3–4 occurred more frequently in Arm B (33%) than in A (13%, P < .01) and C (11%, P < .005). Duration was significantly longer in B than in both A (P = .035) and C (P = .003).
CONCLUSIONS
The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy. The latter is easy and inexpensive but has limited use, as it is drug‐ and schedule‐dependent. The current study is the first double‐blind randomized evaluation of prophylactic chlorhexidine in a large adult patient population with solid tumors receiving highly OM‐inducing chemotherapy. A role for chlorhexidine in the prevention of OM is suggested, which should be evaluated further. Cancer 2008. ©2008 American Cancer Society.